EUVIMEDEUVIMED entdecken
Open Access

Genotype–Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis

Tyler S Brown, Linrui Tang iD, Shaheed Vally Omar, Lavania Joseph, Graeme Meintjes, Gary Maartens, Sean Wasserman, N Sarita Shah, Maha R Farhat, Neel R Gandhi, Nazir Ismail, James C M Brust und 1 weitere

Clinical Infectious Diseases · 17.02.2024 · 78 (2) · 269-276

DOI: 10.1093/cid/ciad596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 24.10.2023. Verfasst von Tyler S Brown und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Wellcome Trust, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging resistance to bedaquiline (BDQ) threatens to undermine advances in the treatment of drug-resistant tuberculosis (DRTB). Characterizing serial Mycobacterium tuberculosis (Mtb) isolates collected during BDQ-based treatment can provide insights into the etiologies of BDQ resistance in this important group of DRTB patients.

Methods

We measured mycobacteria growth indicator tube (MGIT)–based BDQ minimum inhibitory concentrations (MICs) of Mtb isolates collected from 195 individuals with no prior BDQ exposure who were receiving BDQ-based treatment for DRTB. We conducted whole-genome sequencing on serial Mtb isolates from all participants who had any isolate with a BDQ MIC >1 collected before or after starting treatment (95 total Mtb isolates from 24 participants).

Results

Sixteen of 24 participants had BDQ-resistant TB (MGIT MIC ≥4 µg/mL) and 8 had BDQ-intermediate infections (MGIT MIC = 2 µg/mL). Participants with pre-existing resistance outnumbered those with resistance acquired during treatment, and 8 of 24 participants had polyclonal infections. BDQ resistance was observed across multiple Mtb strain types and involved a diverse catalog of mmpR5 (Rv0678) mutations, but no mutations in atpE or pepQ. Nine pairs of participants shared genetically similar isolates separated by <5 single nucleotide polymorphisms, concerning for potential transmitted BDQ resistance.

Conclusions

BDQ-resistant TB can arise via multiple, overlapping processes, including transmission of strains with pre-existing resistance. Capturing the within-host diversity of these infections could potentially improve clinical diagnosis, population-level surveillance, and molecular diagnostic test development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisTuberculosis, Multidrug-ResistantHumansAntitubercular AgentsDiarylquinolinesGenotypePhenotypeMicrobial Sensitivity Tests

Stichwörter der Autor:innen

bedaquilinedrug resistancetuberculosiswhole-genome sequencing

Substanzen

bedaquilineAntitubercular AgentsDiarylquinolines

Autor:innen und Institutionen

  • Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.
  • Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Department of Molecular Medicine & Hematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, and Department of Medicine, University of Cape Town, Cape Town, South Africa.

ORCID-Profile: Linrui Tang, Barun Mathema

Förderung

  • NIAID NIH HHS
  • Wellcome Trust
  • NCATS NIH HHS
  • FIC NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Einstein-Rockefeller-CUNY Center for AIDS Research
  • Emory University Center for AIDS Research

Zitieren

APA

Brown, T. S., Tang, L., Omar, S. V., Joseph, L., Meintjes, G., Maartens, G., Wasserman, S., Shah, N. S., Farhat, M. R., Gandhi, N. R., Ismail, N., Brust, J. C. M., & Mathema, B. (2024). Genotype–Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis. Clinical Infectious Diseases, 78(2), 269-276. https://doi.org/10.1093/cid/ciad596

Vancouver

Brown TS, Tang L, Omar SV, Joseph L, Meintjes G, Maartens G, et al. Genotype–Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis. Clinical Infectious Diseases. 2024;78(2):269-276. doi:10.1093/cid/ciad596

BibTeX
@article{Brown2024,
  author = {Brown, Tyler S and Tang, Linrui and Omar, Shaheed Vally and Joseph, Lavania and Meintjes, Graeme and Maartens, Gary and Wasserman, Sean and Shah, N Sarita and Farhat, Maha R and Gandhi, Neel R and Ismail, Nazir and Brust, James C M and Mathema, Barun},
  title = {Genotype–Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {2},
  pages = {269--276},
  doi = {10.1093/cid/ciad596}
}
Kostenlos starten →